MedicalResearch.com Interview with Genevieve Kenney Ph.D
Senior Fellow and Co-Director, Health Policy Center
The Urban Institute
2100 M Street NW Washington DC 20037
MedicalResearch.com: What are the main findings of the study?
Dr. Kenney: Our study is the first published analysis that draws on physical examinations, laboratory tests, and patient reports to assess the health needs and health risks of uninsured adults who could be eligible for Medicaid coverage under the Affordable Care Act relative to the adults who are already enrolled in Medicaid.
Our main findings are that the uninsured adults who could enroll under the ACA are less likely than the adults with Medicaid coverage to be obese and to have functional limitations and chronic health problems, such as hypertension, hypercholesterolemia, or diabetes, but that the uninsured adults with these chronic conditions are less likely to be aware that they have them and less likely to have the condition under control. In comparison to the Medicaid population, the uninsured adults in our study were also less likely to have seen a health professional in the prior year and to have a routine place for care. The rates of undiagnosed and uncontrolled chronic health care problems found in our study indicate that millions of low-income uninsured adults are currently at risk of premature mortality and other significant health issues. These findings provide new evidence of the potential health benefits associated with the Medicaid expansion under the Affordable Care Act.
MedicalResearch.com Interview with
Dr. Karen E. Joynt, MD MPH
Cardiovascular Division
Brigham and Women's Hospital and VA Boston Healthcare System
Department of Health Policy and Management, Harvard School of Public Health
MedicalResearch.com: What are the main findings of the study?
Dr. Joynt: The main findings of the study were two-fold.
First, high-cost patients in Medicare (the top decile of spenders) are responsible for about 80% of inpatient spending in the Medicare program, so understanding more about these patients' patterns of care is really important.
Second, we found that only about 10% of acute-care spending for these high-cost Medicare patients were for causes that we generally think of as preventable in the short term, like uncontrolled diabetes, COPD, or heart failure.
The rest of the spending was for acute conditions that we generally don't think of as preventable (at least in the short term), such as orthopedic procedures, sepsis, and cancer.
MedicalResearch.com eInterview with:
Peter Muennig, MD, MPH
Associate Professor of Health Policy and Management
Columbia University School of Public Health
NY City, NY
MedicalResearch.com: What are the main findings of the study?
Answer: We find that one of the welfare time limit experiments that led to welfare reform in the United States in 1996 led to increases in mortality rates among experimental group participants over 14-15 years of follow up.
MedicalResearch.com: Were any of the findings unexpected?
Answer: Yes. Welfare reform led to increases in employment among the experimental group participants. Employment has long been hypothesized to reduce mortality. We examined this experiment to explore whether increases in employment among those exposed to time limits on welfare reduced mortality. We found instead they increased mortality.
MedicalResearch.com eInterview with: M. Kit Degado, MD, MS
Instructor, Emergency Medicine
Affiliated Faculty, Centers for Health Policy/Primary Care and Outcomes Research
Stanford University School of Medicine
kdelgado@stanford.edu
MedicalResearch.com: What are the main findings of the study?
Dr. Degado:
MedicalResearch.com Interview with Gabriel Brooks MD
Fellow, Medical Oncology
Dana-Farber Cancer Institute
MedicalResearch.com: What are the main findings of the study?
Dr. Brooks: First, we found that there is substantial regional variation in Medicare spending for patients with advanced cancer. For patients with a new diagnosis of advanced stage cancer, spending in the six months following diagnosis varied by 32% between regions in the highest and lowest quintiles of spending. And for patients who died from cancer, spending in the last six months of life varied by 41% between the highest and lowest spending regions.
Second, we tested the association between area-level spending and survival from the time of advanced cancer diagnosis. We found that there was no consistent association between increasing spending and survival for any of the five cancer sites included in our study (non-small cell lung cancer, colorectal cancer, pancreas cancer, breast cancer and prostate cancer).
AURORA, Colo. -- As scientists continue making breakthroughs in personalized cancer treatment, delivering those therapies in the most cost effective manner has become increasingly important. Now researchers at the University of Colorado School of Medicine have identified new ways of doing just that, allowing more patients to benefit from this...